4.6 Letter

Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials

Journal

BRITISH JOURNAL OF DERMATOLOGY
Volume 181, Issue 4, Pages 841-842

Publisher

WILEY
DOI: 10.1111/bjd.17926

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available